nonlinear regression tool from graphpad prism version 9 (GraphPad Software Inc)
GraphPad Software Inc is a verified supplier 
90
Structured Review
GraphPad Software Inc
nonlinear regression tool from graphpad prism version 9
Nonlinear Regression Tool From Graphpad Prism Version 9, supplied by GraphPad Software Inc, used in various techniques. Bioz Stars score: 90/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/product/nonlinear+regression+tool+from+graphpad+prism+version+9/prism+curve+fitting+software/pmc11911931-46-13-12
Average 90 stars, based on 1 article reviews
Nonlinear Regression Tool From Graphpad Prism Version 9, supplied by GraphPad Software Inc, used in various techniques. Bioz Stars score: 90/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/product/nonlinear+regression+tool+from+graphpad+prism+version+9/prism+curve+fitting+software/pmc11911931-46-13-12
Average 90 stars, based on 1 article reviews
nonlinear regression tool from graphpad prism version 9 - by Bioz Stars,
2026-09
90/100 stars
Images
Related Articles
Software:Article Title: Loss of CYLD promotes splenic marginal zone lymphoma Article Snippet: Parental SL‐15 and SL‐22 cell lines, as well as control (CTL) and CYLD knockout (KO) SL‐15 and SL‐22 cells, were seeded in a 12‐well cell culture plate (10 5 cells/well) in 1 mL of RPMI 1640 (Euroclone) and treated with either DMSO or 1, 2.5, 5, 10, and 20 μM of Ibrutinib for up to 72 h. Cell viability was evaluated by Trypan Blue exclusion and CellTiter‐Glo Luminescent assay (#G7570, Promega) every 24 h. The results were expressed as a percentage of viability calculated by the ratio between the number of live cells treated with ibrutinib and the number of live cells treated with vehicle (DMSO). .. Ibrutinib IC 50 value was calculated using a |